Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR3 | P32745 | 1/20 | 0.47 |
| ▸ | PTPRB | P23467 | 2/20 | 0.44 |
| ▸ | SUCNR1 | Q9BXA5 | 5/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | CTSS | P25774 | 4/20 | 0.40 |
| ▸ | CTSK | P43235 | 3/20 | 0.40 |
| ▸ | CTSL | P07711 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | P4HB | P07237 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CTSA | P10619 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1928548 | 0.88 | SSTR3 (0.46) | SSTR3PTPRBPPARACTSSCTSK | |
| SCHEMBL394603 | 0.88 | PTPRB (0.52) | SSTR3PTPRBPPARACTSSCTSK | |
| SCHEMBL394602 | 0.88 | PTPRB (0.52) | SSTR3PTPRBPPARACTSSCTSK | |
| SCHEMBL1197796 | 0.88 | CYP17A1 (0.40) | SSTR3PTPRBSUCNR1MAPTSCN9A | |
| SCHEMBL14268345 | 0.87 | KLK7 (0.47) | SSTR3PTPRBPPARACTSSCTSL | |
| SCHEMBL14268346 | 0.87 | KLK7 (0.47) | SSTR3PTPRBPPARACTSSCTSL | |
| SCHEMBL27571238 | 0.86 | CTSK (0.50) | SSTR3PTPRBPPARACTSSCTSK | |
| SCHEMBL27571239 | 0.86 | CTSK (0.50) | SSTR3PTPRBPPARACTSSCTSK | |
| SCHEMBL1928018 | 0.86 | SSTR3 (0.45) | SSTR3PTPRBPPARACTSSCTSK | |
| SCHEMBL2073125 | 0.86 | SSTR3 (0.43) | SSTR3PTPRBCTSKMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021420-A1 | New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments | SCRAS | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021420-A1 | New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments | ADCYAP1R1, HPRT1, ALPI | SSTR3 172/4885PTPRB 488/4885SUCNR1 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.